The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

NVO’s success in the past few years is underscored by its marketed semaglutide (GLP-1 agonist) medicines. Wegovy is a ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...

Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

Eli Lilly and Company LLY announced that the FDA has approved its popular obesity drug, Zepbound (tirzepatide) for treating ...

WVE-007 is a novel approach for treating obesity and is designed to silence INHBE to achieve healthy, sustainable weight loss through fat ...

Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...

Explore the world of weight loss drugs. Find out how GLP-1-based drugs can lead to significant weight loss, but also bone and ...

Tiny doses of the weight-loss drug can sidestep its unpleasant side effects, say influencers. But is customising the dose a ...